Over The Counter (OTC) Test Market Size, Share, and Trends 2024 to 2034

The global over the counter (OTC) test market size is calculated at USD 24.69 billion in 2025 and is forecasted to reach around USD 63.35 billion by 2034, accelerating at a CAGR of 11.04% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 5991
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Over The Counter (OTC) Test Market 

5.1. COVID-19 Landscape: Over The Counter (OTC) Test Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Over The Counter (OTC) Test Market, By Product Type

8.1. Over The Counter (OTC) Test Market Revenue and Volume, by Product Type

8.1.1 Glucose Monitoring Test

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Pregnancy & Fertility Test

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Coagulation Monitoring Test

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Urinalysis Test

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Cholesterol Test

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Other Test

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global Over The Counter (OTC) Test Market, By Technology

9.1. Over The Counter (OTC) Test Market Revenue and Volume, by Technology

9.1.1. Lateral Flow Assays

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Immunoassays

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Dipsticks

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Over The Counter (OTC) Test Market, By Distribution Channel

10.1. Over The Counter (OTC) Test Market Revenue and Volume, by Distribution Channel

10.1.1. Hospital Pharmacies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Retail Pharmacies

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Online pharmacies

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Over The Counter (OTC) Test Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type

11.1.2. Market Revenue and Volume Forecast, by Technology

11.1.3. Market Revenue and Volume Forecast, by Distribution Channel

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type

11.1.4.2. Market Revenue and Volume Forecast, by Technology

11.1.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type

11.1.5.2. Market Revenue and Volume Forecast, by Technology

11.1.5.3. Market Revenue and Volume Forecast, by Distribution Channel

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type

11.2.2. Market Revenue and Volume Forecast, by Technology

11.2.3. Market Revenue and Volume Forecast, by Distribution Channel

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type

11.2.4.2. Market Revenue and Volume Forecast, by Technology

11.2.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type

11.2.5.2. Market Revenue and Volume Forecast, by Technology

11.2.5.3. Market Revenue and Volume Forecast, by Distribution Channel

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type

11.2.6.2. Market Revenue and Volume Forecast, by Technology

11.2.6.3. Market Revenue and Volume Forecast, by Distribution Channel

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type

11.2.7.2. Market Revenue and Volume Forecast, by Technology

11.2.7.3. Market Revenue and Volume Forecast, by Distribution Channel

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type

11.3.2. Market Revenue and Volume Forecast, by Technology

11.3.3. Market Revenue and Volume Forecast, by Distribution Channel

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type

11.3.4.2. Market Revenue and Volume Forecast, by Technology

11.3.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type

11.3.5.2. Market Revenue and Volume Forecast, by Technology

11.3.5.3. Market Revenue and Volume Forecast, by Distribution Channel

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type

11.3.6.2. Market Revenue and Volume Forecast, by Technology

11.3.6.3. Market Revenue and Volume Forecast, by Distribution Channel

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type

11.3.7.2. Market Revenue and Volume Forecast, by Technology

11.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.2. Market Revenue and Volume Forecast, by Technology

11.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type

11.4.4.2. Market Revenue and Volume Forecast, by Technology

11.4.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type

11.4.5.2. Market Revenue and Volume Forecast, by Technology

11.4.5.3. Market Revenue and Volume Forecast, by Distribution Channel

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type

11.4.6.2. Market Revenue and Volume Forecast, by Technology

11.4.6.3. Market Revenue and Volume Forecast, by Distribution Channel

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type

11.4.7.2. Market Revenue and Volume Forecast, by Technology

11.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.2. Market Revenue and Volume Forecast, by Technology

11.5.3. Market Revenue and Volume Forecast, by Distribution Channel

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type

11.5.4.2. Market Revenue and Volume Forecast, by Technology

11.5.4.3. Market Revenue and Volume Forecast, by Distribution Channel

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type

11.5.5.2. Market Revenue and Volume Forecast, by Technology

11.5.5.3. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Abingdon Health PLC

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. AccuBioTech Co., Ltd

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Acon Laboratories Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. B. Braun Melsungen AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Becton Dickinson and Company

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Clip Health

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Dario Health Corp

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Ellume Health Ltd

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Eurofins Scientific Group

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global over the counter (OTC) test market size is expected to grow from USD 22.23 billion in 2024 to USD 63.35 billion by 2034.

The over the counter (OTC) test market is anticipated to grow at a CAGR of 11.04% between 2025 and 2034.

The major players operating in the over the counter (OTC) test market are Abbott Laboratories, Abingdon Health PLC , AccuBioTech Co., Ltd., Acon Laboratories Inc., B. Braun Melsungen AG , Becton Dickinson and Company, Clip Health, Dario Health Corp, Ellume Health Ltd, Eurofins Scientific Group, F. Hoffmann-La Roche AG, Lia Diagnostics Inc, Lifescan IP Holdings, LLC, Lucira Health, Inc, Now Diagnostics Inc, Orasure Technologies Inc, PHC Holdings Corporation , Quidel Corporation, SD Biosensor Inc., Sinocare Inc., and others.

The driving factors of the over the counter (OTC) test market are the rising awareness about the benefits of self-medication and preventative medications is boosting the growth of over the counter (OTC) test market.

North America region will lead the global over the counter (OTC) test market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client